% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Pham:304123,
author = {T. T. Pham and K. Nimptsch and K. Aleksandrova and M. Jenab
and V. Fedirko and A. Olsen and A. Tjønneland and C. Cadeau
and G. Severi and M. B. Schulze and R. Turzanski-Fortner$^*$
and V. Katzke$^*$ and C. Agnoli and C. Sacerdote and R.
Tumino and S. Signoriello and C. Trobajo-Sanmartín and
J.-H. Gómez and M.-D. Chirlaque and M.-J. Sánchez and M.
Crous-Bou and A. May and A. Heath and D. Aune and E.
Weiderpass and T. Pischon},
title = {{C}irculating fatty acid binding protein 4 ({FABP}-4)
concentrations and mortality in individuals with colorectal
cancer in the {E}uropean {P}rospective {I}nvestigation into
{C}ancer and {N}utrition study.},
journal = {International journal of cancer},
volume = {158},
number = {3},
issn = {0020-7136},
address = {Bognor Regis},
publisher = {Wiley-Liss},
reportid = {DKFZ-2025-01786},
pages = {546-559},
year = {2026},
note = {2026 Feb 1;158(3):546-559},
abstract = {Human fatty acid binding protein-4 (FABP-4), a protein
elevated in obesity that promotes colon cancer cell
invasiveness and metastasis, may be associated with higher
mortality in individuals with colorectal cancer (CRC) and
may serve as a mediator of the obesity-mortality association
in these individuals. We used a causal diagram to inform
covariate selection and applied Cox proportional hazards
models to estimate hazard ratios (HRs) for CRC-specific,
non-CRC-specific, and all-cause mortality by FABP-4 levels
measured in baseline blood samples from 1371 incident CRC
cases from the European Prospective Investigation into
Cancer and Nutrition cohort. Competing risk analyses were
adapted for CRC and non-CRC deaths. Mediation analyses were
conducted to estimate total effects (TEs), direct effects
(DEs), and mediation proportions (MPs) by FABP-4 of
pre-diagnostic body mass index (BMI) on mortality. In the
fully adjusted model including BMI, higher circulating
FABP-4 concentrations were associated with higher CRC
mortality (HRQ4vsQ1 = 1.49; $95\%$ CI: 1.11-2.00) and
all-cause mortality (HRQ4vsQ1 = 1.49; $95\%$ CI: 1.15-1.93),
but not statistically associated with non-CRC mortality
(HRQ4vsQ1 = 1.51; $95\%$ CI: 0.82-2.76). The TE and DE per 5
kg/m2 of BMI on all-cause mortality were 1.21; $95\%$ CI:
1.10-1.34, and 1.13; $95\%$ CI: 1.02-1.26, respectively,
with a MP of $34.5\%$ (p = .002) by FABP-4. For CRC-specific
and non-CRC-specific mortality, MPs by FABP-4 were $33.7\%$
(p = .03) and $36.1\%$ (p = .02), respectively. In
conclusion, higher concentrations of FABP-4 were associated
with higher CRC-specific and all-cause mortality in
individuals with CRC. FABP-4 was a significant partial
mediator of the adiposity-mortality relationship in
individuals with CRC.},
keywords = {EPIC (Other) / FABP‐4 (Other) / human fatty acid binding
protein‐4 (Other) / incident colorectal cancer (Other) /
mortality (Other)},
cin = {C180 / C020},
ddc = {610},
cid = {I:(DE-He78)C180-20160331 / I:(DE-He78)C020-20160331},
pnm = {313 - Krebsrisikofaktoren und Prävention (POF4-313)},
pid = {G:(DE-HGF)POF4-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:40857027},
doi = {10.1002/ijc.70090},
url = {https://inrepo02.dkfz.de/record/304123},
}